Sarcomatrix Therapeutics Corp.
PrivateLast Round
Seed
Aug 22, 2025
Est. Valuation
$14.25M
Total Funding Raised
$1.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sarcomatrix Therapeutics Corp. is a biotechnology company that develops novel small-molecule therapeutics and protein replacement therapies for muscle-wasting diseases such as muscular dystrophy, sarcopenia, and cachexia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sarcomatrix Therapeutics Corp. Comparables
Compare Sarcomatrix Therapeutics Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strykagen Corp | 89% | |
| Epirium Bio | 71% | |
| Biophytis SA | 71% |
Sarcomatrix Therapeutics Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2025 | ||||
| Crowdfunding | Jul 8, 2024 | ||||
| Grant | Sep 20, 2023 |
Sarcomatrix Therapeutics Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 648% MoM, reaching 1.8K.
- Apr 21, 2026
Monthly visitors grew 1574% MoM, from 27 to 452.
Sarcomatrix Therapeutics Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sarcomatrix Therapeutics Corp.'s valuation, stock price, and market status.
Is Sarcomatrix Therapeutics Corp. a public or private company?
Sarcomatrix Therapeutics Corp. is a private company.
What is the current stock price of Sarcomatrix Therapeutics Corp.?
Sarcomatrix Therapeutics Corp. is a private company with no public stock price. No recent secondary market data is available.
How much is Sarcomatrix Therapeutics Corp. worth (valuation)?
Sarcomatrix Therapeutics Corp.'s valuation is estimated at $14.3M based on funding round data.
Can I buy Sarcomatrix Therapeutics Corp. stock?
Sarcomatrix Therapeutics Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sarcomatrix Therapeutics Corp.'s last funding round?
Sarcomatrix Therapeutics Corp.'s most recent funding round was Seed on July 8, 2024.
Who are the main investors in Sarcomatrix Therapeutics Corp.?
Key investors in Sarcomatrix Therapeutics Corp. include National Institutes of Health (NIH).
Will Sarcomatrix Therapeutics Corp. IPO soon?
No public IPO plans have been announced for Sarcomatrix Therapeutics Corp..
How can I track Sarcomatrix Therapeutics Corp. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sarcomatrix Therapeutics Corp.'s secondary market activity and sign up for updates.